Conflicts of Interest: Yuan A, None; Ahmad BU, None; Xu D, None; Martin DF, None; Sears JE, None; Schachat AP, None; Singh RP: consultant for Thrombogenics, Regeneron, Alcon, and Bausch and Lomb; Kaiser PK: consultant for Bayer, Regeneron, Genentech, Kanghong, Novartis, and Alcon; Ehlers JP: speaker for Regeneron, consultant and speaker for Thrombogenics.
Alex Yuan, Baseer U. Ahmad, David Xu, et al. Comparison of intravitreal ranibizumab and bevacizumab for the treatment of macular edema secondary to retinal vein occlusion. Int J Ophthalmol, 2014,7(1):86-91
Copy